Concepedia

Apexa Bernard

AB

Statistics

Publications

8

Citations

293

H-Index

8

Active since

2012

Affiliations

Janssen (Belgium)(Current)

Janssen (United States)

BC Cancer Agency

Apexa Bernard is an author at Janssen (Belgium) specializing in pharmacology, pharmacokinetics, and pharmacy.

Publications per year

2012–2017

8

Publications

8

Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration‐resistant prostate cancer

Kim N., Jennifer L. Spratlin, Christian Kollmannsberger et al. · The Journal of Clinical Pharmacology · 2015 · 104 citations

, , +15

Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men

Milin Acharya, Apexa Bernard, Martha Gonzalez et al. · Cancer Chemotherapy and Pharmacology · 2012 · 48 citations · Full text

, , +13

Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer

K. N., Anthony W. Tolcher, Peter P. Lee et al. · Cancer Chemotherapy and Pharmacology · 2012 · 34 citations

, , +13

Impact on abiraterone pharmacokinetics and safety: Open‐label drug–drug interaction studies with ketoconazole and rifampicin

Apexa Bernard, Nicole Vaccaro, Milin Acharya et al. · Clinical Pharmacology in Drug Development · 2014 · 32 citations

, , +15

In Vitro and In Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity

Johan Monbaliu, Martha Gonzalez, Apexa Bernard et al. · Drug Metabolism and Disposition · 2016 · 28 citations · Full text

, , +17

1–5 of 8